Pharmacophore-directed retrosynthesis applied to the ion channel inhibitor waixenicin A; multicomponent, enantioselective organocatalytic synthesis of tetrahydropyridazinones.
dc.contributor.advisor | Romo, Daniel. | |
dc.creator | Kiledal, Sigrid Anne, 1995- | |
dc.date.accessioned | 2024-07-17T14:10:19Z | |
dc.date.available | 2024-07-17T14:10:19Z | |
dc.date.created | 2023-08 | |
dc.date.issued | 2023-08 | |
dc.date.submitted | August 2023 | |
dc.date.updated | 2024-07-17T14:10:19Z | |
dc.description.abstract | Waixenicin A (waixA) is a xenicane molecule isolated from the marine coral Sarcothelia edmondsoni, and is a known selective inhibitor of the ion channel TRPM7, which mediates a lethal calcium cascade caused by hypoxic ischemic brain injury. This marine diterpene possesses a strained (E)-cyclononene trans-fused to a dihydropyran and a side-chain bearing a vinylogous bis-acetoxy acetal. In addition to its synthetic challenges, waixA is also of biological interest due to potent inhibitions of the ion channel transient receptor potential melastatin 7 (TRPM7), a divalent cation channel essential for maintaining magnesium homeostasis. In addition, this channel plays a critical role in the toxic calcium ion cascade induced by hypoxic-ischemic events. We thus set out to apply pharmacophore-directed retrosynthesis (PDR) to enable access to derivatives of varying complexity en route to the natural product to provide further SAR data for TRPM7 inhibition. In this work, we have accomplished the synthesis of several monocyclic derivatives containing both a simplified sidechain and that found in the natural product. The synthesis of these derivatives and further progress toward annulation of the cyclononene will be presented along with inhibition data toward TRPM7. Secondly, an enantioselective, multicomponent reaction was developed for the synthesis of tetrahydropyridazinones (THPZ), which are well-represented molecules within the realm of pharmaceuticals. This one-pot sequence utilized chiral acylammonium salts generated from tertiary amine catalysts, malonates, and azodicarboxylates in a nucleophile catalyzed-Michael-proton-transfer-lactamization. Subsequent derivatizations of these THPZs were also explored, which revealed unexpected ring-contractions and rearrangements and further displayed the utility of these substrates. Additionally, the use of allyl methyl malonate and a deallylative decarboxylation also enabled the formation of a second stereocenter. | |
dc.format.mimetype | application/pdf | |
dc.identifier.uri | ||
dc.identifier.uri | https://hdl.handle.net/2104/12823 | |
dc.language.iso | English | |
dc.rights.accessrights | No access – contact librarywebmaster@baylor.edu | |
dc.title | Pharmacophore-directed retrosynthesis applied to the ion channel inhibitor waixenicin A; multicomponent, enantioselective organocatalytic synthesis of tetrahydropyridazinones. | |
dc.type | Thesis | |
dc.type.material | text | |
local.embargo.lift | 2028-08-01 | |
local.embargo.terms | 2028-08-01 | |
thesis.degree.department | Baylor University. Dept. of Chemistry & Biochemistry. | |
thesis.degree.grantor | Baylor University | |
thesis.degree.name | Ph.D. | |
thesis.degree.program | Chemistry | |
thesis.degree.school | Baylor University |
Files
Original bundle
1 - 4 of 4
No Thumbnail Available
- Name:
- KILEDAL-PRIMARY-2023.pdf
- Size:
- 12.79 MB
- Format:
- Adobe Portable Document Format
No Thumbnail Available
- Name:
- 1698673956395-Kiledal_Rightslink® by Copyright Clearance_APS .pdf
- Size:
- 207.72 KB
- Format:
- Adobe Portable Document Format
No Thumbnail Available
- Name:
- 1690483326404-ETD Copyright updated 10.10.22 DR (1).pdf
- Size:
- 148.57 KB
- Format:
- Adobe Portable Document Format
No Thumbnail Available
- Name:
- 1698673971218-Kiledal_Rightslink® by Copyright Clearance Center.pdf
- Size:
- 201.87 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1